SEARCH

SEARCH BY CITATION

References

  • Bassett IV, Wang B, Chetty S et al. (2010) Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clinical Infectious Diseases51, 823829.
  • Bassett IV, Chetty S, Wang B et al. (2012) Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa. Journal of Acquired Immune Deficiency Syndromes59, 2530.
  • Battegay M, Nüesch R, Hirschel B & Kaufmann GR (2006) Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infectious Diseases6, 280287.
  • Bergsbaken T, Fink SL & Cookson BT (2009) Pyroptosis: host cell death and inflammation. Nature Reviews Microbiology7, 99109.
  • Breen R, Miller RF, Gorsuch T et al. (2006) Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. Journal of Infectious Diseases193, 14371440.
  • Castelnuovo B, Manabe YC, Kiragga A, Kamya M, Easterbrook P & Kambugu A (2009) Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban african cohort. Clinical Infectious Diseases49, 965972.
  • Cingolani A, Cozzi Lepri A, Castagna A et al. (2011) Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition. Clinical Infectious Diseases54, 853861.
  • Corbett EL, Watt CJ, Walker N et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine163, 10091021.
  • Doitsh G, Cavrois M, Lassen KG et al. (2010) Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell143, 789801.
  • Eggena MP, Barugahare B, Okello M et al. (2005) T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection. Journal of Infectious Diseases191, 694701.
  • Egger SB, Petoumenos KP, Kamarulzaman AM et al. (2009) Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: the Asia pacific HIV observational database (APHOD). Journal of Acquired Immune Deficiency Syndromes50, 513520.
  • Geng E, Vittinghoff E, Nachega JB et al. 2010. The immunologic efficacy of antiretroviral therapy among HIV-infected patients in North America and Africa. Conference on Retrovirology and Opportunistic Infections. San Francisco, United States.
  • Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AIM & Manabe YC (2010) Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa. PLoS ONE5, e10527.
  • Hermans S, van Leth F, Manabe Y, Hoepelman A, Lange J & Kambugu A (2012a) Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study. HIV Medicine13, 337344.
  • Hermans SM, Castelnuovo B, Katabira C et al. (2012b) Integration of HIV and TB services results in improved TB treatment outcomes and earlier, prioritized ART initiation in a large urban HIV clinic in Uganda. Journal of Acquired Immune Deficiency Syndromes60, e2935.
  • Hunt PW, Martin JN, Sinclair E et al. (2003) T cell activation Is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. Journal of Infectious Diseases187, 15341543.
  • Jones BE, Oo MM, Taikwel EK et al. (1997) CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clinical Infectious Diseases24, 988991.
  • Kalou M, Sassan-Morokro M, Abouya L et al. (2005) Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and co-trimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Côte d’Ivoire. Journal of Medical Virology75, 202208.
  • Lawn SD (2004) AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. Journal of Infection48, 112.
  • Lawn SD, Badri M & Wood R (2005) Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS19, 21092116.
  • Lawn S, Myer L, Bekker LG & Wood R (2006a) CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infectious Diseases6, 59.
  • Lawn SD, Myer L, Bekker LG & Wood R (2006b) Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS20, 16051612.
  • Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008a) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS22, 18971908.
  • Lawn SD, Wilkinson RJ, Lipman MC & Wood R (2008b) Immune reconstitution and “unmasking” of tuberculosis during antiretroviral therapy. American Journal of Respiratory and Critical Care Medicine177, 680685.
  • Lawn SD, Myer L, Edwards D, Bekker LG & Wood R (2009) Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS23, 17171725.
  • Lawn SD, Kranzer K, Edwards DJ, McNally M, Bekker LG & Wood R (2010a) Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy. AIDS24, 13231328.
  • Lawn SD, Wood R, De Cock KM, Kranzer K, Lewis JJ & Churchyard GJ (2010b) Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infectious Diseases10, 489498.
  • Mahan CS, Walusimbi M, Johnson DF et al. (2010) Tuberculosis treatment in HIV infected Ugandans with CD4 counts >350 cells/mm3 reduces immune activation with no effect on HIV load or CD4 count. PLoS ONE5, e9138.
  • Manabe YC, Breen R, Perti T, Girardi E & Sterling TR (2009) Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy. Journal of Infectious Diseases199, 437444.
  • Martin DJ, Sim JG, Sole GJ et al. (1995) CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology8, 386391.
  • Mtei L, Matee M, Herfort O et al. (2005) High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clinical Infectious Diseases40, 15001507.
  • Nakanjako D, Ssewanyana I, Mayanja-Kizza H et al. (2011) High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infectious Diseases11, 43.
  • Negredo E, Massanella M, Puig J et al. (2010) Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications. Clinical Infectious Diseases50, 13001308.
  • Patel A, Patel K, Patel J, Shah N, Patel B & Rani S (2004) Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral-naive patients in India who are coinfected with tuberculosis and HIV-1. Journal of Acquired Immune Deficiency Syndromes37, 11661169.
  • Toossi Z (2003) Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. Journal of Infectious Diseases188, 11461155.
  • Tuboi SH, Brinkhof MW, Egger M et al. (2007) Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration. Journal of Acquired Immune Deficiency Syndromes45, 5259.
  • World Health Organization2011. Report on Global Tuberculosis Control. WHO, Geneva.
  • Zhou J, Sirisanthana T, Kiertiburanakul S et al. (2010) Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. BMC Infectious Diseases10, 361.